Use the Guide
Browse the Guide
Portfolio Discussions
Dr. Kelly's Review
Use the Guide
Guide to Retirement
Client Presentation
Employment & the Fed
Navigating fiscal uncertainty
European Markets
U.S. Recovery
Employment & the Fed
Navigating fiscal uncertainty
European Markets
U.S. Recovery
Featured Topics
Fixed Income
Income Opportunities
U.S. Equities
Global Growth
Looking for other topics? Visit the Library
Choose a Shortcut

JPMorgan Dynamic Growth Fund - C (DGXCX)

JPMorgan Dynamic Growth Fund - C (DGXCX)
Overview Performance and Ratings Holdings and Details Management Dividends and Capital Gains Fees and Expenses Sales Resources
Top ten holdings (as of 10/31/2015)
1. Alphabet, Inc. 6.3%
2., Inc. 5.9%
3. MasterCard, Inc., Class A 5.9%
4. Facebook, Inc., Class A 5.8%
5. Regeneron Pharmaceuticals, Inc. 4.8%
6. Gilead Sciences, Inc. 4.7%
7. Home Depot, Inc. (The) 4.3%
8. Charles Schwab Corp. (The) 4.1%
9. Celgene Corp. 4.1%
10., Inc. 4.0%
Total of top ten 49.9%
Sector breakdown* (as of 10/31/2015)
Consumer Discretionary 24.6%
Consumer Staples 2.5%
Energy 3.3%
Financials 4.1%
Health Care 20.7%
Industrials 5.4%
Information Technology 32.0%
Materials 3.1%
Short-Term Investments 4.3%

* Due to rounding, values may not total 100%.

Top contributors and detractors (as of 10/31/2015)
Top 5 quarterly contributors
1., Inc. 0.85%
2. Alphabet, Inc. 0.69%
3. Priceline Group, Inc. (The) 0.47%
4. Facebook, Inc., Class A 0.46%
5. Starbucks Corp. 0.33%
Top 5 quarterly detractors
1. Charles Schwab Corp. (The) -0.57%
2. Illumina, Inc. -0.55%
3. Kansas City Southern -0.52%
4. BioMarin Pharmaceutical, Inc. -0.50%
5. Vertex Pharmaceuticals, Inc. -0.44%
Portfolio stats (as of 10/31/2015)
Number of Holdings 32
Fund Assets $373.11
(in millions)
Turnover Ratio 73.50%
(Trailing 12 month) (6/30/2015)
Wtd. Avg. Market Cap $134.06
(in billions)
P/E Ratio 27.12
(1 yr. forecast)
P/B Ratio 6.03
Risk measures* (as of 10/31/2015)
Beta 1.06
Sharpe Ratio 1.45

*All risk measures are based on a 3 year time period.

What's this? Mouse over an  underlined  word to see its definition. Check out our glossary >

The Fund is subject to management risk and may not achieve its objective if the adviser's expectations regarding particular securities or markets are not met. The Fund is also subject to equity market risk. The price of equity securities may rise or fall because of changes in the broad market or changes in a company's financial condition, sometimes rapidly or unpredictably.

Investments in derivatives may be riskier than other types of investments. They may be more sensitive to changes in economic or market conditions than other types of investments. Many derivatives create leverage, which could lead to greater volatility and losses that significantly exceed the original investment.

The Fund may invest foreign securities which are subject to additional risks including political and economic risks, greater volatility, currency fluctuations, higher transaction costs, delayed settlement, possible foreign controls on investment, and less stringent investor protection and disclosure standards of foreign markets.

Total return assumes reinvestment of income.

The top 10 holdings listed reflect only the Fund's long-term investments. Short-term investments are excluded. Holdings are subject to change. The holdings listed should not be considered recommendations to purchase or sell a particular security. Each individual security is calculated as a percentage of the aggregate market value of the securities held in the Fund and does not include the use of derivative positions, where applicable.

P/E ratio: the number by which earnings per share is multiplied to estimate a stock's value.

P/B ratio: the relationship between a stock's price and the book value of that stock.

Beta: The systematic risk of a Fund. The beta of a Fund is its sensitivity to a benchmark. A Fund with a beta of 1.0 is as risky as the benchmark and would therefore provide expected returns equal to those of the market during both up and down periods.

Sharpe ratio: A risk-adjusted measure that determines the reward per unit of risk. The numerator is the difference between the Fund's annualized return and the annualized return of the risk-free instrument and the denominator is the Fund's standard deviation. The Sharpe ratio is calculated over a 36-month period based on the Fund's returns. The greater the Fund's Sharpe ratio, the better its risk-adjusted performance has been. A negative Sharpe ratio indicates that a risk-free instrument would perform better than the Fund. The Sharpe ratio shown is based on the Fund's Class A Shares or the oldest share class, where Class A Shares are not available.

Standard deviation/Volatility: A statistical measure of the degree to which the Fund's returns have varied from its historical average. The higher the standard deviation, the wider the range of returns from its average and the greater the historical volatility. The standard deviation is calculated over a 36-month period based on Fund's monthly returns. The standard deviation shown is based on the Fund's Class A Shares or the oldest share class, where Class A Shares are not available.

EPS: Total earnings divided by the number of shares outstanding.

Risk measures are calculated based upon the Funds' broad-based index as stated in the prospectus.